Dianthus Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

robot
Abstract generation in progress

This article is a notice of the proposed sale of securities by Dianthus Therapeutics, filed pursuant to Rule 144. It is a mandatory disclosure related to the sale of restricted and control securities.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin